福莫特罗
沙美特罗
医学
沙丁胺醇
维持疗法
富马酸福莫特罗
不利影响
恶化
哮喘
麻醉
药理学
内科学
化疗
布地奈德
作者
Helen K. Reddel,Guy Brusselle,Rosa Lamarca,Per Gustafson,Gary P. Anderson,Carin Jorup
标识
DOI:10.1016/j.jaip.2023.03.046
摘要
What is already known about this topic?Global Initiative for Asthma (GINA) and National Asthma Education and Prevention Program (NAEPP) guidelines recommend inhaled corticosteroid (ICS)-formoterol as the preferred controller and reliever for asthma, either in combination with maintenance ICS-formoterol or (in GINA) alone.However, for patients taking a non-formoterol ICS-long-acting b 2 -agonist as maintenance therapy, the recommended reliever is a short-acting b 2 -agonist (SABA) or (in GINA 2023) combination ICS
科研通智能强力驱动
Strongly Powered by AbleSci AI